The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Newborn Calf Serum-Global Market Insights and Sales Trends 2025

Newborn Calf Serum-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1846507

No of Pages : 126

Synopsis
Newborn Calf Serum is the most widely used growth supplement for cell culture media because of its high content of embryonic growth promoting factors. When used at appropriate concentrations it supplies many defined and undefined components that have been shown to satisfy specific metabolic requirements for the culture of cells.
The global Newborn Calf Serum market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Newborn Calf Serum in various end use industries. The expanding demands from the Scientific Research and Industrial Production, are propelling Newborn Calf Serum market. USA-sourced, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the South America-sourced segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Newborn Calf Serum, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Newborn Calf Serum market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Newborn Calf Serum market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Newborn Calf Serum sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Newborn Calf Serum covered in this report include Life Technologies, Thermo Fisher, GE Healthcare, Sigma-Aldrich, Merck, Moregate BioTech, Gemini, Atlanta Biologicals and Tissue Culture Biologicals, etc.
The global Newborn Calf Serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Life Technologies
Thermo Fisher
GE Healthcare
Sigma-Aldrich
Merck
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
VWR
Corning
Animal Technologies
Serana
WISENT
Peak Serum
Seroxlab
NorthBio
Bio Nutrientes Brasil
Lanzhou Minhai
Zhejiang Tianhang Biotechnology
ExCell Bio
Jin Yuan Kang
Global Newborn Calf Serum market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Newborn Calf Serum market, Segment by Type:
USA-sourced
South America-sourced
Australia-sourced
Others
Global Newborn Calf Serum market, by Application
Scientific Research
Industrial Production
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Newborn Calf Serum manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Newborn Calf Serum in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Newborn Calf Serum Market Overview
1.1 Newborn Calf Serum Product Overview
1.2 Newborn Calf Serum Market Segment by Type
1.2.1 USA-sourced
1.2.2 South America-sourced
1.2.3 Australia-sourced
1.2.4 Others
1.3 Global Newborn Calf Serum Market Size by Type
1.3.1 Global Newborn Calf Serum Market Size Overview by Type (2018-2029)
1.3.2 Global Newborn Calf Serum Historic Market Size Review by Type (2018-2023)
1.3.3 Global Newborn Calf Serum Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Newborn Calf Serum Sales Breakdown by Type (2018-2023)
1.4.2 Europe Newborn Calf Serum Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Newborn Calf Serum Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Newborn Calf Serum Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Newborn Calf Serum Sales Breakdown by Type (2018-2023)
2 Global Newborn Calf Serum Market Competition by Company
2.1 Global Top Players by Newborn Calf Serum Sales (2018-2023)
2.2 Global Top Players by Newborn Calf Serum Revenue (2018-2023)
2.3 Global Top Players by Newborn Calf Serum Price (2018-2023)
2.4 Global Top Manufacturers Newborn Calf Serum Manufacturing Base Distribution, Sales Area, Product Type
2.5 Newborn Calf Serum Market Competitive Situation and Trends
2.5.1 Newborn Calf Serum Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Newborn Calf Serum Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Newborn Calf Serum as of 2022)
2.7 Date of Key Manufacturers Enter into Newborn Calf Serum Market
2.8 Key Manufacturers Newborn Calf Serum Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Newborn Calf Serum Status and Outlook by Region
3.1 Global Newborn Calf Serum Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Newborn Calf Serum Historic Market Size by Region
3.2.1 Global Newborn Calf Serum Sales in Volume by Region (2018-2023)
3.2.2 Global Newborn Calf Serum Sales in Value by Region (2018-2023)
3.2.3 Global Newborn Calf Serum Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Newborn Calf Serum Forecasted Market Size by Region
3.3.1 Global Newborn Calf Serum Sales in Volume by Region (2024-2029)
3.3.2 Global Newborn Calf Serum Sales in Value by Region (2024-2029)
3.3.3 Global Newborn Calf Serum Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Newborn Calf Serum by Application
4.1 Newborn Calf Serum Market Segment by Application
4.1.1 Scientific Research
4.1.2 Industrial Production
4.2 Global Newborn Calf Serum Market Size by Application
4.2.1 Global Newborn Calf Serum Market Size Overview by Application (2018-2029)
4.2.2 Global Newborn Calf Serum Historic Market Size Review by Application (2018-2023)
4.2.3 Global Newborn Calf Serum Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Newborn Calf Serum Sales Breakdown by Application (2018-2023)
4.3.2 Europe Newborn Calf Serum Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Newborn Calf Serum Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Newborn Calf Serum Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Newborn Calf Serum Sales Breakdown by Application (2018-2023)
5 North America Newborn Calf Serum by Country
5.1 North America Newborn Calf Serum Historic Market Size by Country
5.1.1 North America Newborn Calf Serum Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Newborn Calf Serum Sales in Volume by Country (2018-2023)
5.1.3 North America Newborn Calf Serum Sales in Value by Country (2018-2023)
5.2 North America Newborn Calf Serum Forecasted Market Size by Country
5.2.1 North America Newborn Calf Serum Sales in Volume by Country (2024-2029)
5.2.2 North America Newborn Calf Serum Sales in Value by Country (2024-2029)
6 Europe Newborn Calf Serum by Country
6.1 Europe Newborn Calf Serum Historic Market Size by Country
6.1.1 Europe Newborn Calf Serum Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Newborn Calf Serum Sales in Volume by Country (2018-2023)
6.1.3 Europe Newborn Calf Serum Sales in Value by Country (2018-2023)
6.2 Europe Newborn Calf Serum Forecasted Market Size by Country
6.2.1 Europe Newborn Calf Serum Sales in Volume by Country (2024-2029)
6.2.2 Europe Newborn Calf Serum Sales in Value by Country (2024-2029)
7 Asia-Pacific Newborn Calf Serum by Region
7.1 Asia-Pacific Newborn Calf Serum Historic Market Size by Region
7.1.1 Asia-Pacific Newborn Calf Serum Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Newborn Calf Serum Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Newborn Calf Serum Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Newborn Calf Serum Forecasted Market Size by Region
7.2.1 Asia-Pacific Newborn Calf Serum Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Newborn Calf Serum Sales in Value by Region (2024-2029)
8 Latin America Newborn Calf Serum by Country
8.1 Latin America Newborn Calf Serum Historic Market Size by Country
8.1.1 Latin America Newborn Calf Serum Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Newborn Calf Serum Sales in Volume by Country (2018-2023)
8.1.3 Latin America Newborn Calf Serum Sales in Value by Country (2018-2023)
8.2 Latin America Newborn Calf Serum Forecasted Market Size by Country
8.2.1 Latin America Newborn Calf Serum Sales in Volume by Country (2024-2029)
8.2.2 Latin America Newborn Calf Serum Sales in Value by Country (2024-2029)
9 Middle East and Africa Newborn Calf Serum by Country
9.1 Middle East and Africa Newborn Calf Serum Historic Market Size by Country
9.1.1 Middle East and Africa Newborn Calf Serum Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Newborn Calf Serum Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Newborn Calf Serum Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Newborn Calf Serum Forecasted Market Size by Country
9.2.1 Middle East and Africa Newborn Calf Serum Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Newborn Calf Serum Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Life Technologies
10.1.1 Life Technologies Company Information
10.1.2 Life Technologies Introduction and Business Overview
10.1.3 Life Technologies Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Life Technologies Newborn Calf Serum Products Offered
10.1.5 Life Technologies Recent Development
10.2 Thermo Fisher
10.2.1 Thermo Fisher Company Information
10.2.2 Thermo Fisher Introduction and Business Overview
10.2.3 Thermo Fisher Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Thermo Fisher Newborn Calf Serum Products Offered
10.2.5 Thermo Fisher Recent Development
10.3 GE Healthcare
10.3.1 GE Healthcare Company Information
10.3.2 GE Healthcare Introduction and Business Overview
10.3.3 GE Healthcare Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GE Healthcare Newborn Calf Serum Products Offered
10.3.5 GE Healthcare Recent Development
10.4 Sigma-Aldrich
10.4.1 Sigma-Aldrich Company Information
10.4.2 Sigma-Aldrich Introduction and Business Overview
10.4.3 Sigma-Aldrich Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sigma-Aldrich Newborn Calf Serum Products Offered
10.4.5 Sigma-Aldrich Recent Development
10.5 Merck
10.5.1 Merck Company Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Merck Newborn Calf Serum Products Offered
10.5.5 Merck Recent Development
10.6 Moregate BioTech
10.6.1 Moregate BioTech Company Information
10.6.2 Moregate BioTech Introduction and Business Overview
10.6.3 Moregate BioTech Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Moregate BioTech Newborn Calf Serum Products Offered
10.6.5 Moregate BioTech Recent Development
10.7 Gemini
10.7.1 Gemini Company Information
10.7.2 Gemini Introduction and Business Overview
10.7.3 Gemini Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Gemini Newborn Calf Serum Products Offered
10.7.5 Gemini Recent Development
10.8 Atlanta Biologicals
10.8.1 Atlanta Biologicals Company Information
10.8.2 Atlanta Biologicals Introduction and Business Overview
10.8.3 Atlanta Biologicals Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Atlanta Biologicals Newborn Calf Serum Products Offered
10.8.5 Atlanta Biologicals Recent Development
10.9 Tissue Culture Biologicals
10.9.1 Tissue Culture Biologicals Company Information
10.9.2 Tissue Culture Biologicals Introduction and Business Overview
10.9.3 Tissue Culture Biologicals Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Tissue Culture Biologicals Newborn Calf Serum Products Offered
10.9.5 Tissue Culture Biologicals Recent Development
10.10 Bovogen
10.10.1 Bovogen Company Information
10.10.2 Bovogen Introduction and Business Overview
10.10.3 Bovogen Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bovogen Newborn Calf Serum Products Offered
10.10.5 Bovogen Recent Development
10.11 Biowest
10.11.1 Biowest Company Information
10.11.2 Biowest Introduction and Business Overview
10.11.3 Biowest Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Biowest Newborn Calf Serum Products Offered
10.11.5 Biowest Recent Development
10.12 Internegocios
10.12.1 Internegocios Company Information
10.12.2 Internegocios Introduction and Business Overview
10.12.3 Internegocios Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Internegocios Newborn Calf Serum Products Offered
10.12.5 Internegocios Recent Development
10.13 RMBIO
10.13.1 RMBIO Company Information
10.13.2 RMBIO Introduction and Business Overview
10.13.3 RMBIO Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.13.4 RMBIO Newborn Calf Serum Products Offered
10.13.5 RMBIO Recent Development
10.14 Biological Industries
10.14.1 Biological Industries Company Information
10.14.2 Biological Industries Introduction and Business Overview
10.14.3 Biological Industries Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Biological Industries Newborn Calf Serum Products Offered
10.14.5 Biological Industries Recent Development
10.15 PAN-Biotech
10.15.1 PAN-Biotech Company Information
10.15.2 PAN-Biotech Introduction and Business Overview
10.15.3 PAN-Biotech Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.15.4 PAN-Biotech Newborn Calf Serum Products Offered
10.15.5 PAN-Biotech Recent Development
10.16 VWR
10.16.1 VWR Company Information
10.16.2 VWR Introduction and Business Overview
10.16.3 VWR Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.16.4 VWR Newborn Calf Serum Products Offered
10.16.5 VWR Recent Development
10.17 Corning
10.17.1 Corning Company Information
10.17.2 Corning Introduction and Business Overview
10.17.3 Corning Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Corning Newborn Calf Serum Products Offered
10.17.5 Corning Recent Development
10.18 Animal Technologies
10.18.1 Animal Technologies Company Information
10.18.2 Animal Technologies Introduction and Business Overview
10.18.3 Animal Technologies Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Animal Technologies Newborn Calf Serum Products Offered
10.18.5 Animal Technologies Recent Development
10.19 Serana
10.19.1 Serana Company Information
10.19.2 Serana Introduction and Business Overview
10.19.3 Serana Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Serana Newborn Calf Serum Products Offered
10.19.5 Serana Recent Development
10.20 WISENT
10.20.1 WISENT Company Information
10.20.2 WISENT Introduction and Business Overview
10.20.3 WISENT Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.20.4 WISENT Newborn Calf Serum Products Offered
10.20.5 WISENT Recent Development
10.21 Peak Serum
10.21.1 Peak Serum Company Information
10.21.2 Peak Serum Introduction and Business Overview
10.21.3 Peak Serum Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Peak Serum Newborn Calf Serum Products Offered
10.21.5 Peak Serum Recent Development
10.22 Seroxlab
10.22.1 Seroxlab Company Information
10.22.2 Seroxlab Introduction and Business Overview
10.22.3 Seroxlab Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Seroxlab Newborn Calf Serum Products Offered
10.22.5 Seroxlab Recent Development
10.23 NorthBio
10.23.1 NorthBio Company Information
10.23.2 NorthBio Introduction and Business Overview
10.23.3 NorthBio Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.23.4 NorthBio Newborn Calf Serum Products Offered
10.23.5 NorthBio Recent Development
10.24 Bio Nutrientes Brasil
10.24.1 Bio Nutrientes Brasil Company Information
10.24.2 Bio Nutrientes Brasil Introduction and Business Overview
10.24.3 Bio Nutrientes Brasil Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.24.4 Bio Nutrientes Brasil Newborn Calf Serum Products Offered
10.24.5 Bio Nutrientes Brasil Recent Development
10.25 Lanzhou Minhai
10.25.1 Lanzhou Minhai Company Information
10.25.2 Lanzhou Minhai Introduction and Business Overview
10.25.3 Lanzhou Minhai Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.25.4 Lanzhou Minhai Newborn Calf Serum Products Offered
10.25.5 Lanzhou Minhai Recent Development
10.26 Zhejiang Tianhang Biotechnology
10.26.1 Zhejiang Tianhang Biotechnology Company Information
10.26.2 Zhejiang Tianhang Biotechnology Introduction and Business Overview
10.26.3 Zhejiang Tianhang Biotechnology Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.26.4 Zhejiang Tianhang Biotechnology Newborn Calf Serum Products Offered
10.26.5 Zhejiang Tianhang Biotechnology Recent Development
10.27 ExCell Bio
10.27.1 ExCell Bio Company Information
10.27.2 ExCell Bio Introduction and Business Overview
10.27.3 ExCell Bio Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.27.4 ExCell Bio Newborn Calf Serum Products Offered
10.27.5 ExCell Bio Recent Development
10.28 Jin Yuan Kang
10.28.1 Jin Yuan Kang Company Information
10.28.2 Jin Yuan Kang Introduction and Business Overview
10.28.3 Jin Yuan Kang Newborn Calf Serum Sales, Revenue and Gross Margin (2018-2023)
10.28.4 Jin Yuan Kang Newborn Calf Serum Products Offered
10.28.5 Jin Yuan Kang Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Newborn Calf Serum Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Newborn Calf Serum Industrial Chain Analysis
11.4 Newborn Calf Serum Market Dynamics
11.4.1 Newborn Calf Serum Industry Trends
11.4.2 Newborn Calf Serum Market Drivers
11.4.3 Newborn Calf Serum Market Challenges
11.4.4 Newborn Calf Serum Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Newborn Calf Serum Distributors
12.3 Newborn Calf Serum Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’